Compare OUT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OUT | HAE |
|---|---|---|
| Founded | 2013 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.9B |
| IPO Year | N/A | 1991 |
| Metric | OUT | HAE |
|---|---|---|
| Price | $25.04 | $57.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $25.20 | ★ $86.00 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | ★ 4.79% | N/A |
| EPS Growth | N/A | ★ 43.84 |
| EPS | 0.70 | ★ 3.65 |
| Revenue | ★ $1,811,600,000.00 | $1,318,275,000.00 |
| Revenue This Year | $0.99 | N/A |
| Revenue Next Year | $3.95 | $5.86 |
| P/E Ratio | $35.97 | ★ $15.82 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $12.95 | $47.32 |
| 52 Week High | $27.04 | $87.32 |
| Indicator | OUT | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 49.21 | 22.70 |
| Support Level | $26.09 | $55.95 |
| Resistance Level | $27.04 | $60.50 |
| Average True Range (ATR) | 0.72 | 2.46 |
| MACD | -0.08 | -0.59 |
| Stochastic Oscillator | 29.82 | 14.35 |
Outfront Media Inc is a real estate investment trust involved in the ownership of advertising space on its portfolio of billboards and transit displays. The Company generates revenue in the form of rental income by allowing other companies to advertise on its properties and structures under short-term contracts. Outfront Media segments its operations into the United States and International units. Although it also owns assets in Canada and Latin America, the company derives the vast majority of its revenue from billboard advertising agreements in the U.S. Roughly half of the U.S. division's revenue comes from its displays in the New York City and Los Angeles markets. Outfront Media's customers include entities within the retail, television, healthcare, and entertainment industries.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.